Transcriptional and functional differences in stem cell populations isolated from extraocular and limb muscles


Pacheco-Pinedo E. C. , Budak M. T. , Zeiger U., Jorgensen L. H. , Bogdanovich S., Schroder H. D. , ...Daha Fazla

PHYSIOLOGICAL GENOMICS, cilt.37, ss.35-42, 2009 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Pacheco-Pinedo EC, Budak MT, Zeiger U, Jorgensen LH, Bog-danovich S, Schroder HD, Rubinstein NA, Khurana TS. Transcriptional and functional differences in stem cell populations isolated from extraocular and limb muscles. Physiol Genomics 37: 35-42, 2009. First published December 30, 2008; doi: 10.1152/physiolgenomics.00051.2008. - The extraocular muscles (EOMs) are a distinct muscle group that displays an array of unique contractile, structural, and regenerative properties. They also have differential sensitivity to certain diseases and are enigmatically spared in Duchenne muscular dystrophy (DMD). The EOMs are so distinct from other skeletal muscles that the term "allotype" has been coined to highlight EOM group-specific properties. We hypothesized that increased and distinct stem cells may underlie the continual myogenesis noted in EOM. The side population (SP) stem cells were isolated and studied. EOMs had 15 x higher SP cell content compared with limb muscles. Expression profiling revealed 348 transcripts that define the EOM-SP transcriptome. Over 92% of transcripts were SP specific, because they were absent in previous whole muscle microarray studies. Cultured EOM-SP cells revealed superior in vitro proliferative capacity. Finally, assays of the committed progenitors or satellite cells performed on myofibers isolated from EOM and limb muscles independently validated the increased proliferative capacity of these muscles. We suggest a model in which unique EOM stem cells contribute to the continual myogenesis noted in EOM and consistent with a role for their sparing in DMD. We believe the greater numbers of stem cells, their unique transcriptome, the greater proliferative capacity of EOM stem cells, and the greater number of satellite cells also offer clues for novel cell-based therapeutic strategies.